https://phosphorylasesignals.c....om/index.php/assessi
This is often revolutionary in a syndrome that has neither a measurable signal for the disease nor a targeted therapy. While there are currently no miRNA-based therapies focused for ARDS, therapies concentrating on miRNA have actually reached period II clinical trials to treat an array of diseases. Further studies may produce a unique miRNA profile pattern that serves as a biomarker or as targets for miRNA-based pharmacologic t
Like
Comment
Share
